Symptom Tracking App for Liver Cancer Immunotherapy
Part of Cancer, Digestive system clinical trials.
This trial tests whether using a smartphone app to regularly report your symptoms can help you and your doctor manage side effects better during immunotherapy treatment for liver cancer. It is a study where you would be randomly assigned to either use the app or receive usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with hepatocellular carcinoma (a type of liver cancer).
- You are currently receiving immunotherapy treatment.
- You are able and willing to use a smartphone or tablet to answer health questions.
- You can understand Mandarin Chinese.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and tissue samples from people with liver cancer to find markers that can predict how well treatment works and whether the cancer might come back. It may help doctors personalize treatment and follow-up care.
This trial tests whether a behavioral program delivered through your smartphone can improve survival and quality of life for people whose liver cancer cannot be surgically removed. You and a caregiver will use WeChat to stay connected and complete tasks from home.
This study tests a mobile app that lets cancer patients report their symptoms and quality of life during cancer treatment. It aims to improve communication between patients and their care team, which may lead to better support and outcomes.
This study tests a smartphone/tablet app that helps children who have finished cancer treatment and their caregivers manage early symptoms that may come back after treatment. It may help families track symptoms and get supportive guidance during the early survivorship period.
This trial uses a smartphone app to track your symptoms during radiation treatment for head and neck cancer. It aims to help your care team catch problems early and improve your quality of life.
This study looks at a genetic test that may predict how well liver cancer patients respond to combination treatment with targeted therapy and immunotherapy. If eligible, your stored tumor tissue will be analyzed to see if a specific gene pattern can tell whether this treatment works for you.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.